Indoco''s formulation plant at Baddi (Plant III) receives EU GMP Certification
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
German Health Authority (Berlin) inspected Indoco Remedies' Oral Solid Dosage (OSD) manufacturing facility at Baddi (Plant III) from April 22-27, 2026, and the facility has received EU GMP certification confirming compliance with EC Directive Good Manufacturing Practice requirements. This certification validates the quality standards of the facility and enables the company to supply pharmaceutical products to European Union markets. Indoco is a fully integrated pharmaceutical company with US$ 175 million turnover, operating 10 manufacturing facilities with approvals from major regulatory bodies including USFDA and UK-MHRA.
This EU GMP certification enhances Indoco's ability to export formulations to European markets, potentially leading to new business opportunities and hard currency revenues. It validates the company's manufacturing quality standards to global regulatory benchmarks.